SLC35B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.543600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.492400E-01
Normal-vs-Stage2
3.391200E-01
Normal-vs-Stage3
8.998600E-01
Normal-vs-Stage4
2.615800E-01
Stage1-vs-Stage2
4.233600E-01
Stage1-vs-Stage3
3.649200E-01
Stage1-vs-Stage4
5.691400E-01
Stage2-vs-Stage3
4.009800E-01
Stage2-vs-Stage4
8.418200E-01
Stage3-vs-Stage4
5.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.497000E-01
Normal-vs-AfricanAmerican
2.116200E-01
Normal-vs-Asian
5.426400E-01
Caucasian-vs-AfricanAmerican
8.178400E-01
Caucasian-vs-Asian
2.143500E-02
AfricanAmerican-vs-Asian
2.247400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.658200E-01
Normal-vs-Female
3.302800E-01
Male-vs-Female
4.944000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.646200E-01
Normal-vs-Age(41-60Yrs)
3.097200E-01
Normal-vs-Age(61-80Yrs)
3.929800E-01
Normal-vs-Age(81-100Yrs)
7.757600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.429200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.370200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.975000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.575900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.207400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.206400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.096800E-01
Normal-vs-Daily Drinker
4.962800E-01
Normal-vs-Weekly Drinker
2.900000E-01
Normal-vs-Occasional Drinker
2.240800E-01
Normal-vs-Social Drinker
3.570000E-01
Non Drinker-vs-Daily Drinker
3.897000E-01
Non Drinker-vs-Weekly Drinker
4.554400E-01
Non Drinker-vs-Occasional Drinker
1.836460E-02
Non Drinker-vs-Social Drinker
1.815410E-01
Daily Drinker-vs-Weekly Drinker
7.944600E-01
Daily Drinker-vs-Occasional Drinker
6.460500E-02
Daily Drinker-vs-Social Drinker
5.439200E-01
Weekly Drinker-vs-Occasional Drinker
3.807500E-02
Weekly Drinker-vs-Social Drinker
3.828400E-01
Occasional Drinker-vs-Social Drinker
1.978390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.836800E-01
Normal-vs-Grade 2
1.068360E-01
Normal-vs-Grade 3
6.131000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.103900E-02
Grade 1-vs-Grade 3
1.997990E-02
Grade 1-vs-Grade 4
2.836800E-01
Grade 2-vs-Grade 3
4.848000E-01
Grade 2-vs-Grade 4
1.068360E-01
Grade 3-vs-Grade 4
6.131000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.124600E-01
Normal-vs-NonDiabetic
2.706600E-01
Diabetic-vs-NonDiabetic
2.874200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.525200E-01
Normal-vs-NoPancreatitis
3.836800E-01
Pancreatitis-vs-NoPancreatitis
6.597700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.334200E-01
Normal-vs-N1
3.807400E-01
N0-vs-N1
3.406000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.475500E-02
Normal-vs-TP53-NonMutant
3.381800E-01
TP53-Mutant-vs-TP53-NonMutant
4.594400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
